RPG Life Sciences Reports Mixed Financial Results Amid Profit Growth and Sales Decline in July 2025

Jul 25 2025 09:32 PM IST
share
Share Via
RPG Life Sciences announced its financial results for the quarter ending March 2025, revealing a year-on-year growth in Profit After Tax to Rs 56.68 crore. However, challenges include a decline in Profit Before Tax and net sales, alongside increased non-operating income, indicating a complex financial landscape.
RPG Life Sciences has recently reported its financial results for the quarter ending March 2025, with the announcement made on July 25, 2025. The company operates within the Pharmaceuticals & Biotechnology sector and is categorized as a small-cap entity.

The financial performance for this quarter reflects a mixed picture. Notably, the Profit After Tax (PAT) for the latest six months stands at Rs 56.68 crore, showcasing a year-on-year growth of 42.76%. This positive trend in PAT indicates a favorable trajectory in profitability for the company. Additionally, the Earnings per Share (EPS) reached Rs 70.96, marking the highest level in the last five quarters, which suggests an enhancement in earnings for shareholders.

Conversely, the results also highlight some challenges. The Profit Before Tax less Other Income (PBT) has shown a decline, recorded at Rs 19.94 crore, which represents a significant drop compared to the average PBT of the previous four quarters. Similarly, net sales for the quarter amounted to Rs 143.09 crore, reflecting a decrease against the previous four-quarter average. Furthermore, while non-operating income reached its highest in five quarters at Rs 5.06 crore, the sustainability of this income from non-business activities remains uncertain.

In light of these developments, RPG Life Sciences has experienced adjustments in its evaluation, reflecting the complexities of its financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News